Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Market sentiment signals for Enliven Therapeutics (ELVN): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Buy
14 analysts
Options Flow (P/C)
—
Avg Consensus PT
$68
+47.7%
Highest Price Target
$82
+79.3%
Lowest Price Target
$27
-41.0%
Short Interest
21.0%
Rising — Bearish
Insider Activity (30d)
Neutral
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Nov 6, 2026 | Guggenheim | Michael Schmidt— | +70.5% | $78 → $78 | Maintained | Buy |
| Oct 19, 2026 | HC Wainwright & Co. | Robert Burns— | +59.6% | $65 → $73 | Maintained | Buy |